SINOMED(688108) 中国证券报-中证网·2025-03-25 22:54Group 1 - The core point of the announcement is that Sino Medical Technology Co., Ltd.'s subsidiary, Sino Shenchang Medical Technology Co., Ltd., has secured a credit line of RMB 49 million from the Industrial and Commercial Bank of China, which can be used for various financial services including loans and trade financing [1][2]. - The credit line agreement is valid from January 23, 2025, to March 31, 2026, allowing for one-time or multiple uses within this period [1]. - This credit approval reflects the financial institution's recognition of Sino Shenchang's business development prospects and is expected to improve the company's financial condition and provide strong funding support for its operations [2]. Group 2 - The financing through bank credit is anticipated to enhance the company's strength and align with its overall interests, without significantly impacting its normal operations [2]. - The announcement was made by the board of directors of Sino Medical Technology Co., Ltd. on March 26, 2025 [4].